Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06882447
What this trial is testing

QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer Stage IVB
Northern Jiangsu People's Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00057889
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)UnknownNCT02356419
What this trial is testing

RESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics

Who this might be right for
Chronic Renal Failure
Shenyang Sunshine Pharmaceutical Co., LTD. 40
Not applicableNot Yet RecruitingNCT07455071
What this trial is testing

A Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247) in Study Participants With HRD-negative Epithelial Ovarian Cancer

Who this might be right for
HRD-negative Epithelial Ovarian Cancer
Peking University Third Hospital 9
Post-approval studies (Phase 4)UnknownNCT04199364
What this trial is testing

Medium vs Low Oxygen Threshold for the Surfactant Administration

Who this might be right for
Respiratory Distress Syndrome
Virgilio Paolo Carnielli 200
Early research (Phase 1)Study completedNCT03189498
What this trial is testing

Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal Function

Who this might be right for
Renal Insufficiency
Janssen Pharmaceutica N.V., Belgium 38
Early research (Phase 1)Study completedNCT00705367
What this trial is testing

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 13
Testing effectiveness (Phase 2)UnknownNCT05137171
What this trial is testing

AK105 Combined With Anlotinib in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
The First Affiliated Hospital of Zhengzhou University 36
Large-scale testing (Phase 3)Ended earlyNCT05316467
What this trial is testing

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Who this might be right for
Endometrial CarcinomaObeseOverweight+1 more
Xiaojun Chen 8
Early research (Phase 1)Study completedNCT03318809
What this trial is testing

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function

Who this might be right for
Heart Failure
Amgen 12
Early research (Phase 1)WithdrawnNCT01265017
What this trial is testing

Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Sansum Diabetes Research Institute
Early research (Phase 1)Ended earlyNCT02808052
What this trial is testing

Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency

Who this might be right for
Renal Insufficiency, AcuteRenal Insufficiency, ChronicHealthy Subjects
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710847
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Who this might be right for
Neoplasms, ColorectalSolid TumorColon Cancer+2 more
GlaxoSmithKline 14
Testing effectiveness (Phase 2)Ended earlyNCT03389438
What this trial is testing

Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma

Who this might be right for
Urinary Bladder Neoplasm
Beijing Huanxing Cancer Hospital 6
Early research (Phase 1)Study completedNCT01309438
What this trial is testing

Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function

Who this might be right for
HealthyRenal Insufficiency
Janssen Research & Development, LLC 29
Testing effectiveness (Phase 2)Study completedNCT00192049
What this trial is testing

Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 90
Not applicableUnknownNCT06363708
What this trial is testing

Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Zhongnan Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05316376
What this trial is testing

Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial

Who this might be right for
Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 78
Testing effectiveness (Phase 2)Looking for participantsNCT04644289
What this trial is testing

WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC

Who this might be right for
Epithelial Ovarian Cancer
AGO Research GmbH 60
Early research (Phase 1)Study completedNCT06723535
What this trial is testing

Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

Who this might be right for
Kidney Failure, ChronicHealthy VolunteersRenal Impairment
Bristol-Myers Squibb 27
Next Page